End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
92.5 ZAR | +0.53% | -2.63% | -4.84% |
05-15 | South Africa's president signs health insurance bill into law | RE |
04-19 | South African insurer Old Mutual gets green light to establish bank | RE |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.67 for the current year.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.84% | 4.51B | - | ||
+0.88% | 69.29B | B- | ||
+5.50% | 49.46B | B | ||
+3.66% | 48.75B | B+ | ||
+17.83% | 44.91B | B+ | ||
+9.06% | 40.62B | B+ | ||
+20.40% | 34.09B | B | ||
-4.92% | 27.56B | B | ||
-10.60% | 26.6B | B- | ||
+27.21% | 26.35B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DSY Stock
- DSBP Stock
- Ratings Discovery Limited